The Community Resource in Targeted Therapies
Driving Knowledge. Empowering Change. Optimizing Outcomes.
ONCAlert | Upfront Therapy for mRCC

Using Antibody-Mediated Neutralization of Soluble MIC to Enhance Response to CTLA-4 Blockade

Jennifer Wu, PhD
Published Online: 11:43 PM, Fri November 10, 2017

Jennifer Wu, PhD, professor, Northwestern University, Robert H. Lurie Comprehensive Cancer Center, discusses how soluble MIC can impact response to anti-CTLA-4 therapy during The Society for Immunotherapy of Cancer (SITC) 32nd Annual Meeting.
 

Copyright © TargetedOnc 2018 Intellisphere, LLC. All Rights Reserved.